Here are the 8-K filings from Starry Sea Acquisition Corp Unit (SSEAU) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow SSEAU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SSEAU filings page.
STARRY SEA ACQUISITION CORP deposited $60,000 into its trust account to extend its deadline to complete an initial business combination by one month, from November 7, 2026, to December 7, 2026. SuperiorMed Healthcare, an affiliate of SuperiorMed, loaned the extension amount; SSEA expects to issue the lender a promissory note.
The merger agreement contemplates SSEA merging into its wholly owned subsidiary SuperiorMed Healthcare Group, which would survive as the publicly traded entity. A separate merger subsidiary would merge into SuperiorMed, leaving SuperiorMed as a wholly owned subsidiary of the surviving entity. Purchaser and SuperiorMed will file a registration statement that includes a proxy statement and prospectus for the proposed transaction.
Starry Sea Acquisition Corp. (SSEA) amended its earlier disclosure to state that 3,896,270 ordinary shares were tendered for redemption in connection with the October 19, 2026 Extension Meeting. The Monthly Extension Fee will be $60,000 for each one-month extension.
STARRY SEA ACQUISITION CORP (SSEA) shareholders approved amendments to the company’s charter and trust agreement, extending the Combination Period from November 7, 2026, to November 7, 2027, by up to 12 additional one-month periods. The trust amendment provides for a monthly deposit equal to the lesser of $60,000 per month for all remaining public shares or $0.033 for each remaining public share after redemptions. The company also stated that the Monthly Extension Fee will be $60,000 for each one-month extension.
In connection with the vote, 3,895,270 ordinary shares were tendered for redemption. As of September 16, 2026, SSEA had 7,635,871 issued and outstanding ordinary shares entitled to vote. Holders voted 6,406,986 shares at the October 19, 2026 meeting, representing 83.91% of shares entitled to vote and constituting a quorum. The charter and trust amendment proposals each passed with 5,197,330 votes for and 1,209,656 against; the adjournment proposal passed with 5,707,672 for and 699,314 against.
STARRY SEA ACQUISITION CORP (SSEA) reported that redemption requests covering 601,847 public shares were withdrawn by the October 15, 2026 deadline; 3,895,270 public shares remain tendered for redemption.
The extraordinary general meeting, originally scheduled for October 9, 2026, was postponed to October 19, 2026, at 9:00 a.m. Eastern Time to allow additional time to engage with shareholders. The remaining tendered shares include new redemption requests received between October 7 and October 15, 2026.
Starry Sea Acquisition Corp. postponed its Extraordinary General Meeting from 10:00 a.m. Eastern Time on October 9, 2026, to 9:00 a.m. Eastern Time on October 19, 2026, to allow more time to engage with shareholders.
The company reported that, as of October 7, 2026, the original redemption deadline, 4,281,993 public shares had been submitted for redemption, leaving 1,468,007 public shares outstanding. It is seeking reversals of redemption requests for approximately 350,174 public shares; if achieved, at least 1,818,181 public shares would remain outstanding. At that level, the estimated monthly extension contribution is approximately $59,999.97, calculated at $0.033 per remaining public share. The company believes the $60,000 cap would not reduce the effective per-share contribution, assuming at least 1,818,181 public shares remain outstanding.
STARRY SEA ACQUISITION CORP (symbol: SSEA) is the issuer of record for a Form 8-K filing submitted to the SEC.
Starry Sea Acquisition Corp. reported that its planned merger target is no longer moving forward. The company had signed a letter of intent on September 29, 2025 with Forever Young International Limited for a proposed business combination, but the exclusivity period ended on January 12, 2026 without any definitive agreement being signed. As a result, Starry Sea has decided it will not proceed with this proposed transaction.
STARRY SEA ACQUISITION CORP (SSEAU) filed an 8-K reporting that holders of the companys IPO Units may elect to separately trade the underlying Ordinary Shares and Rights, with separate trading expected to begin on or about October 2, 2025. The filing references a press release dated October 1, 2025 as Exhibit 99.1 announcing the change. The disclosure is procedural: it notifies investors that the bundled IPO Units issued at offering will be unbundled for separate trading, and identifies the effective timing for market participants to trade the component securities.
Starry Sea Acquisition Corp entered into a non-binding letter of intent with Forever Young International Limited, a Cayman Islands health industry operator serving medical institutions in China, for a proposed business combination. The LOI grants an exclusivity period during which Starry Sea will not pursue alternative business combination proposals while the parties negotiate a definitive agreement.
The LOI contemplates a pre-money equity value for Forever Young in the range of approximately USD 750 million to USD 900 million, with consideration expected to be paid as rollover equity in the form of ordinary shares of the post-closing public company, each valued at $10 per share. Starry Sea also issued a press release announcing the LOI, and any final transaction would proceed through a proxy statement process for stockholder approval.
Starry Sea Acquisition Corp completed its initial public offering of 5,750,000 units at $10.00 per unit, generating gross proceeds of $57,500,000. Each unit includes one ordinary share and one right to receive one-sixth of an ordinary share upon a future business combination. As of August 11, 2025, the company placed $57,500,000 of net proceeds from the IPO and a concurrent private placement into a trust account for the benefit of public shareholders, with Odyssey Transfer and Trust Company serving as trustee. An audited balance sheet as of that date reflecting these proceeds is provided as an exhibit.